Regencell Bioscience Holdings Ltd
corporate_fare Company Profile
Regencell Bioscience Holdings Ltd (NASDAQ:RGC) is a publicly traded company in the Life Sciences sector. Wiseek monitors RGC SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.
Recent high-impact activity:
- Regencell Bioscience Hit With Class Action Lawsuit Alleging Market Manipulation, DOJ Probe
- Regencell Bioscience Finalizes $20M Direct Offering at 27% Discount
- Regencell Bioscience Finalizes $20M Direct Offering at 25% Discount with Institutional Investor
- Regencell Bioscience Secures $20M in Deeply Discounted Offering
- Regencell Bioscience Reports Deepening Losses, Going Concern Doubt, and Ongoing DOJ Investigation
Financial Snapshot
Insider Transactions
RGC files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.